Pituitary Complications of Checkpoint Inhibitor Use.
Sign Up to like & getrecommendations! Published in 2024 at "Endocrinology"
DOI: 10.1210/endocr/bqae084
Abstract: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events (irAEs), including pituitary complications. Autoimmune hypophysitis, traditionally a rare diagnosis, has become a more frequently encountered… read more here.
Keywords: epidemiology; pituitary complications; use; checkpoint inhibitor ... See more keywords